april 2022 molecular cancer therapeutics648 d ow (Addgene inc)
90
Structured Review
Addgene inc
april 2022 molecular cancer therapeutics648 d ow
April 2022 Molecular Cancer Therapeutics648 D Ow, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/april+2022+molecular+cancer+therapeutics648+d+ow/pET28-mtMetRS+(Plasmid+%2331077)/10__1158_slash_1535___7163__mct___21___0827-85-8-36
Average 90 stars, based on 1 article reviews
April 2022 Molecular Cancer Therapeutics648 D Ow, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/april+2022+molecular+cancer+therapeutics648+d+ow/pET28-mtMetRS+(Plasmid+%2331077)/10__1158_slash_1535___7163__mct___21___0827-85-8-36
Average 90 stars, based on 1 article reviews
april 2022 molecular cancer therapeutics648 d ow - by Bioz Stars,
2026-08
90/100 stars